The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 This international ...
Of the 67 cases, 27 cases (40.3%) were classified as the main duct type IPMT, 35 cases (52.2%) as the branch duct type IPMT, and five cases (7.5%) as the mixed duct type IPMT. There were 12 adenomas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback